Cargando…

An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction

STUDY DESIGN: To review prospective and randomized trials studying anticholinergic therapy for neurogenic bladder in SCI to identify whether trials included standardized clinical evaluation tools and reporting measures now recognized to enhance clinical trial data. METHODS: A systematic search via E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stothers, L, Tsang, B, Nigro, M, Lazare, D, Macnab, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308214/ https://www.ncbi.nlm.nih.gov/pubmed/27241452 http://dx.doi.org/10.1038/sc.2016.63

Ejemplares similares

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis
por: Jaekel, Anke K., et al.
Publicado: (2022)

Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023)

Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms
por: Goodson, Ali B., et al.
Publicado: (2018)

Associations between the severity of obstructive lower urinary tract symptoms and care-seeking behavior in rural Africa: A cross-sectional survey from Uganda
por: Stothers, Lynn, et al.
Publicado: (2017)

New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction
por: Miyazato, Minoru, et al.
Publicado: (2017)

Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020)

Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis
por: Beck, Janina, et al.
Publicado: (2022)

Posing as Ascites: A Case Report on Neurogenic Lower Urinary Tract Dysfunction
por: Sousa, Luís Carlos, et al.
Publicado: (2023)

The concerns of mechanical upper urinary tract obstruction in neurogenic lower urinary tract dysfunction: Beyond augmentation cystoplasty
por: Zhou, Zhonghan, et al.
Publicado: (2023)

Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction
por: Konstantinidis, Charalampos, et al.
Publicado: (2016)

Contractile and Structural Properties of Detrusor from Children with Neurogenic Lower Urinary Tract Dysfunction
por: Johal, Navroop, et al.
Publicado: (2021)

Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children
por: Planta, Dafni, et al.
Publicado: (2023)

Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury
por: Shimizu, Nobutaka, et al.
Publicado: (2023)

Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction
por: Johnson, E. U., et al.
Publicado: (2013)

Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
por: Sammer, Ulla, et al.
Publicado: (2015)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Urine Biomarkers in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review
por: Koukourikis, Periklis, et al.
Publicado: (2023)

Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections
por: Kennelly, Michael, et al.
Publicado: (2019)

Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction
por: Pannek, Jürgen, et al.
Publicado: (2017)

Current Surgical Treatment for Neurogenic Lower Urinary Tract Dysfunction in Patients with Chronic Spinal Cord Injury
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study
por: Zhou, Liqiong, et al.
Publicado: (2022)

Molecular Characterization of Non-Neurogenic and Neurogenic Lower Urinary Tract Dysfunction (LUTD) in SCI-Induced and Partial Bladder Outlet Obstruction Mouse Models
por: von Siebenthal, Michelle, et al.
Publicado: (2023)

Pathophysiology, Clinical Importance, and Management of Neurogenic Lower Urinary Tract Dysfunction Caused by Suprasacral Spinal Cord Injury
por: Hu, H.Z., et al.
Publicado: (2016)

The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis
por: Zhang, Dongxu, et al.
Publicado: (2021)

A Study of DNA Methylation of Bladder Cancer Biomarkers in the Urine of Patients with Neurogenic Lower Urinary Tract Dysfunction
por: Koukourikis, Periklis, et al.
Publicado: (2023)

Monitoring Detrusor Oxygenation and Hemodynamics Noninvasively during Dysfunctional Voiding
por: Macnab, Andrew J., et al.
Publicado: (2012)

Urinary tract infection in the neurogenic bladder
por: Vigil, Humberto R., et al.
Publicado: (2016)

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction
por: Fragalà, Eugenia, et al.
Publicado: (2015)

A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction: Analysis of lower urinary tract function
por: CHO, YOUNG-SAM, et al.
Publicado: (2015)

Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?
por: Dodd, William, et al.
Publicado: (2022)

Clinical practice guidelines for the management of adult patients with neurogenic lower urinary tract dysfunction: a systematic review protocol
por: Zhao, Chun, et al.
Publicado: (2022)

Urinary system complications and long-term treatment compliance in chronic traumatic spinal cord injury patients with neurogenic lower urinary tract dysfunction
por: Dere, Çağlayan, et al.
Publicado: (2022)

Neurogenic Lower Urinary Tract Symptoms, Fatigue, and Depression—Are There Correlations in Persons with Multiple Sclerosis?
por: Jaekel, Anke K., et al.
Publicado: (2023)

Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series
por: Engeler, Daniel S., et al.
Publicado: (2015)

Assessing Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury: Animal Models in Preclinical Neuro-Urology Research
por: Doelman, Adam W., et al.
Publicado: (2023)

Intradetrusor OnabotulinumtoxinA Injections Ameliorate Autonomic Dysreflexia while Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals with Cervical and Upper Thoracic Spinal Cord Injury
por: Walter, Matthias, et al.
Publicado: (2020)

Utility of copeptin and standard inflammatory markers in the diagnostics of upper and lower urinary tract infections
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2015)

Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction
por: Knüpfer, Stephanie C, et al.
Publicado: (2014)

Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial
por: Groah, Suzanne L., et al.
Publicado: (2019)

Tradução para o português An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)
por: Fernandes, Ailton, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3odnpj5qs1hf44v7kd3k5iccph